Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Throughput CRISPR Screening in Hematological Neoplasms. | Cancers (Basel) | 2022 | 35892871 | PubTator, text mining | PubMed |
| Targeting the Microenvironment for Treating Multiple Myeloma. | Int J Mol Sci | 2022 | 35886976 | PubTator, text mining | PubMed |
| A Non-Cell-Autonomous Mode of DNA Damage Response in Soma of Caenorhabditis elegans. | Int J Mol Sci | 2022 | 35886900 | PubTator, text mining | PubMed |
| Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity. | Int J Mol Sci | 2022 | 35886887 | PubTator, text mining | PubMed |
| Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing. | Biomedicines | 2022 | 35884979 | PubTator, text mining | PubMed |
| Exploiting gene dependency to inform drug development for multiple myeloma. | Sci Rep | 2022 | 35882937 | PubTator, text mining | PubMed |
| The Ubiquitin-Proteasome System in Apoptosis and Apoptotic Cell Clearance. | Front Cell Dev Biol | 2022 | 35874820 | PubTator, text mining | PubMed |
| PPAR agonists attenuate lenalidomide's anti-myeloma activity in vitro and in vivo. | Cancer Lett | 2022 | 35872263 | PubTator, text mining | PubMed |
| Compound Interaction Screen on a Photoactivatable Cellulose Membrane (CISCM) Identifies Drug Targets. | ChemMedChem | 2022 | 35867055 | PubTator, text mining | PubMed |
| Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope. | Acta Pharm Sin B | 2022 | 35865099 | PubTator, text mining | PubMed |
| Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation. | ACS Med Chem Lett | 2022 | 35859867 | PubTator, text mining | PubMed |
| Recent advances in cutaneous lupus. | J Autoimmun | 2022 | 35858957 | PubTator, text mining | PubMed |
| Estimating the number of diseases - the concept of rare, ultra-rare, and hyper-rare. | iScience | 2022 | 35856030 | PubTator, text mining | PubMed |
| BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma. | Blood Cancer J | 2022 | 35853853 | PubTator, text mining | PubMed |
| Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma. | Blood | 2022 | 35853156 | PubTator, text mining | PubMed |
| Targeting the deubiquitinase USP7 for degradation with PROTACs. | Chem Commun (Camb) | 2022 | 35852517 | PubTator, text mining | PubMed |
| Taking the EZ way: Targeting enhancer of zeste homolog 2 in B-cell lymphomas. | Blood Rev | 2022 | 35851487 | PubTator, text mining | PubMed |
| SimPLIT: Simplified Sample Preparation for Large-Scale Isobaric Tagging Proteomics. | J Proteome Res | 2022 | 35848491 | PubTator, text mining | PubMed |
| Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma. | EJHaem | 2022 | 35846221 | PubTator, text mining | PubMed |
| Phase Ib study of avadomide (CC-122) in combination with rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma. | EJHaem | 2022 | 35846031 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=56